Literature DB >> 21487907

Subacute inflammatory activation in subjects with acute coronary syndrome and left ventricular dysfunction.

Luisa De Gennaro1, Natale Daniele Brunetti, Deodata Montrone, Fiorella De Rosa, Andrea Cuculo, Matteo Di Biase.   

Abstract

Several lines of evidence indicate that increased inflammatory cytokine levels can be used for risk prediction in patients with acute coronary syndrome (ACS). This study therefore aimed to evaluate correlations between levels of soluble interleukin (IL)-2 receptor (sIL-2r), IL-6, and IL-8 and in-hospital incidence of acute heart failure (AHF) and left ventricular (LV) systolic dysfunction in the subacute phase of ACS. In 48 consecutive patients with ACS, circulating levels of sIL-2r, IL-6, and IL-8 were ascertained 72-96 h after onset of symptoms. Clinical data, LV function, and in-hospital incidence of AHF were also evaluated. IL-8 levels were significantly higher in patients with pulmonary edema (1,829 ± 2,496 vs 456 ± 624 pg/ml, p < 0.05); sIL-2r, IL-6, and IL-8 levels were increased proportionally to Killip class (r = 0.35, p < 0.05; r = 0.48, r = 0.47, p < 0.01) and in patients with LV ejection fraction (LVEF) < 30%. Levels of sIL-2r were inversely related to LVEF in subjects with acute myocardial infarction (r = -0.51, p < 0.05). Soluble IL-2r and IL-8 levels were related to mitral regurgitation severity (r = 0.34, p < 0.05; r = 0.37, p < 0.05). Levels of sIL-2 were proportional to LV end-diastolic diameter (r = 0.49, p < 0.001) and LV end-systolic diameter (r = 0.58, p < 0.001). Number of cytokines with circulating values above upper level of normal was significantly correlated with Killip class and LVEF (r = 0.40, r = -0.38, p < 0.05). sIL-2r, IL-6, and IL-8 are increased in patients with ACS and systolic dysfunction or AHF. These data suggest that inflammatory cytokine activity detectable in peripheral blood may be useful in identifying subjects with a worse clinical course.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21487907     DOI: 10.1007/s10753-011-9326-4

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  45 in total

1.  Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.

Authors:  T Tsutamoto; T Hisanaga; A Wada; K Maeda; M Ohnishi; D Fukai; N Mabuchi; M Sawaki; M Kinoshita
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

2.  Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation.

Authors:  Y Sato; Y Takatsu; K Kataoka; T Yamada; R Taniguchi; S Sasayama; A Matsumori
Journal:  Clin Cardiol       Date:  1999-12       Impact factor: 2.882

3.  Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

Authors:  A Deswal; N J Petersen; A M Feldman; J B Young; B G White; D L Mann
Journal:  Circulation       Date:  2001-04-24       Impact factor: 29.690

4.  Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure.

Authors:  J K Damås; H G Eiken; E Oie; V Bjerkeli; A Yndestad; T Ueland; T Tonnessen; O R Geiran; H Aass; S Simonsen; G Christensen; S S Froland; H Attramadal; L Gullestad; P Aukrust
Journal:  Cardiovasc Res       Date:  2000-09       Impact factor: 10.787

5.  C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings.

Authors:  Natale Daniele Brunetti; Rossella Troccoli; Michele Correale; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  Int J Cardiol       Date:  2005-08-01       Impact factor: 4.164

6.  Elevated circulating levels of C-C chemokines in patients with congestive heart failure.

Authors:  P Aukrust; T Ueland; F Müller; A K Andreassen; I Nordøy; H Aas; J Kjekshus; S Simonsen; S S Frøland; L Gullestad
Journal:  Circulation       Date:  1998-03-31       Impact factor: 29.690

7.  Modulation of IL-8 receptor expression on purified human T lymphocytes is associated with changed chemotactic responses to IL-8.

Authors:  L Xu; D J Kelvin; G Q Ye; D D Taub; A Ben-Baruch; J J Oppenheim; J M Wang
Journal:  J Leukoc Biol       Date:  1995-02       Impact factor: 4.962

Review 8.  Lymphokine production by human T cells in disease states.

Authors:  S Romagnani
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G Torre-Amione; S Kapadia; C Benedict; H Oral; J B Young; D L Mann
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

10.  Nitric oxide synthase activities in human myocardium.

Authors:  A J de Belder; M W Radomski; H J Why; P J Richardson; C A Bucknall; E Salas; J F Martin; S Moncada
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

View more
  11 in total

1.  Elevated levels of sIL-2R, TNF-α and hs-CRP are independent risk factors for post percutaneous coronary intervention coronary slow flow in patients with non-ST segment elevation acute coronary syndrome.

Authors:  Cheng Wang; Yan Wu; Yang Su; Bin Mao; Yihong Luo; Yexiang Yan; Kun Hu; Yi Lu; Wenliang Che; Minying Wan
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-19       Impact factor: 2.357

2.  Thymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction.

Authors:  Hongmei Peng; Jiang Xu; Xiao-Ping Yang; Xiangguo Dai; Edward L Peterson; Oscar A Carretero; Nour-Eddine Rhaleb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

3.  Interactive effects of interferon-gamma functional single nucleotid polymorphism (+874 T/A) with cardiovascular risk factors in coronary heart disease and early myocardial infarction risk.

Authors:  A Basak Akadam-Teker; Erhan Teker; Aynur Daglar-Aday; Kubra Cigdem Pekkoc-Uyanik; Ezgi Irmak Aslan; Özlem Kucukhuseyin; Gulcin Ozkara; Hulya Yılmaz-Aydoğan
Journal:  Mol Biol Rep       Date:  2020-10-26       Impact factor: 2.316

4.  Investigation of the underlying hub genes and mechanisms of reperfusion injury in patients undergoing coronary artery bypass graft surgery by integrated bioinformatic analyses.

Authors:  Zhida Shen; Jiangting Lu; Jiejin Wei; Juanjuan Zhao; Meihui Wang; Ming Wang; Xiaohua Shen; Xue Lü; Binquan Zhou; Yanbo Zhao; Guosheng Fu
Journal:  Ann Transl Med       Date:  2019-11

5.  Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion.

Authors:  Minke H T Hartman; Inge Vreeswijk-Baudoin; Hilde E Groot; Kees W A van de Kolk; Rudolf A de Boer; Irene Mateo Leach; Rozemarijn Vliegenthart; Herman H W Sillje; Pim van der Harst
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

6.  Influence of low-opioid anesthesia in cardiac surgery on dynamics of pro-inflammatory interleukin-6.

Authors:  Oleh Loskutov; Stepan Maruniak; Olexandr Dryzhyna; Ihor Malysh; Volodymyr Kolesnykov; Natalia Korotchuk
Journal:  Kardiochir Torakochirurgia Pol       Date:  2020-04-07

Review 7.  Various aspects of inflammation in heart failure.

Authors:  Mieczysław Dutka; Rafał Bobiński; Izabela Ulman-Włodarz; Maciej Hajduga; Jan Bujok; Celina Pająk; Michał Ćwiertnia
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

8.  Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies.

Authors:  Andrea Gerbino; Cinzia Forleo; Serena Milano; Francesca Piccapane; Giuseppe Procino; Martino Pepe; Mara Piccolo; Piero Guida; Nicoletta Resta; Stefano Favale; Maria Svelto; Monica Carmosino
Journal:  J Cell Mol Med       Date:  2021-11-12       Impact factor: 5.310

Review 9.  The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?

Authors:  Ye-Shun Wu; Bin Zhu; Ai-Lin Luo; Ling Yang; Chun Yang
Journal:  Biomed Res Int       Date:  2018-03-18       Impact factor: 3.411

Review 10.  Role of interleukins in heart failure with reduced ejection fraction.

Authors:  Oliwia Anna Segiet; Adam Piecuch; Lukasz Mielanczyk; Marek Michalski; Ewa Nowalany-Kozielska
Journal:  Anatol J Cardiol       Date:  2019-11       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.